Poster Presentation The 35th Biennial Conference of the Society of Crystallographers in Australia and New Zealand 2024 (Crystal 35)

Inhibiting bacteria heme-piracy using de novo designed proteins (#101)

Daniel Fox 1 , Imogen Samuels 2 , Bradley Spicer 1 , Kazem Asadollahi 2 , Ashleigh Kropp 1 , Chris Lupton 1 , Guy Jameson 2 , Hari Venugopal 3 , Marija Dramicanin 4 , Gavin J Knott 1 , Rhys Grinter 2
  1. Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia
  2. University of Melbourne, Melbourne, VIC, Australia
  3. Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Clayton, Vic, Australia
  4. Protein Production Facility, Walter and Eliza Hall Institute of Medical Research, Melbourne

Iron, an essential nutrient for most bacteria, is often a limiting nutrient during infection, due to the host sequestering free iron as part of the innate immune response. To obtain the iron required for growth, many bacterial pathogens encode proteins capable of extracting the iron-containing cofactor heme directly from host proteins. Pathogenic E. coli and Shigella sp. produce the outer membrane transporter ChuA, which binds host hemoglobin and extracts its heme cofactor, before importing heme into the cell. Heme extraction by ChuA is a dynamic process, with the transporter capable of rapidly extracting heme from hemoglobin in the absence of an external energy source, and without forming a stable ChuA-hemoglobin complex. In this work, we utilise a combination of structural modelling, Cryo-EM, X-ray crystallography, mutagenesis, spectroscopy and phenotypic analysis to understand the mechanistic detail of this process. Based on this understanding we utilise artificial intelligence-based protein design to create binders capable of inhibiting E. coli growth by blocking hemoglobin binding to ChuA. By screening a limited number of these designs, we identify several binders that inhibit E. coli growth at low nanomolar concentrations, without further optimisation. We determine the structure of a subset of these binders, alone and in complex with ChuA, demonstrating that they closely match the computational design. This work demonstrates the utility of de novo-designed proteins for inhibiting bacterial membrane transporters and uses a workflow that could equally be applied to integral membrane proteins in other organisms.